Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung Sort ascending
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Sort ascending Site Standort Division Business Functional Area Erscheinungsdatum
Executive Director, Launch Medical IM Europe Basel (City) Schweiz International Innovative Medicines Research & Development Okt 07, 2024
Analitik mednarodne trgovine (m/ž/d) / International Trade Analyst (m/f/d) Ljubljana Slowenien Operations Innovative Medicines Technical Operations Okt 07, 2024
Associate Analyst - Competitive Intelligence Hyderabad (Office) Indien Operations CTS Marketing Okt 07, 2024
Senior Global Program Regulatory Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Okt 07, 2024
Medical Representative Makati City Philippinen International Innovative Medicines Der Umsatz Okt 07, 2024
Customer Insights & Product Manager - Neurology & Immunology Warsaw Polen International Innovative Medicines Marketing Okt 07, 2024
Global GMP Expert Quality Auditor Mumbai (Head Office) Indien Operations Innovative Medicines Quality Okt 07, 2024
Franchise Medical Head – Cardiovascular and Metabolism Seoul Südkorea International Innovative Medicines Research & Development Okt 07, 2024
Laboratorijski analitik v medfazni analitiki (m/ž/d) Mengeš Slowenien Operations Innovative Medicines Quality Okt 07, 2024
Global Health Quality Lead Kenya Kenia Operations Innovative Medicines Quality Okt 07, 2024
Maintenance Technician (Mechanical) (m/w/d) Schaftenau, Tirol Schaftenau Österreich Operations Innovative Medicines Technical Operations Okt 07, 2024
Associate Director Development Pipeline Operations Hyderabad (Office) Indien Development Innovative Medicines Research & Development Okt 07, 2024
Technical Lead Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 07, 2024
Specialist Platforms Data(Ataccama) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 07, 2024
QC Specialist II (m/w/d), Schaftenau&Kundl, Tirol Schaftenau Österreich Operations Innovative Medicines Quality Okt 07, 2024
Associate Director- Platforms Data Quality (Ataccama) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 07, 2024
Customer Service Specialist: Pharma Supply Chain Prague Tschechische Republik International Innovative Medicines Technical Operations Okt 07, 2024
Associate Director, Talent Acquisition, Projects Hyderabad (Office) Indien People & Organization CTS Humanressourcen Okt 07, 2024
Inženir zagonov in kvalifikacij (m/ž/d) -/ C&Q Engineer II (m/f/d) Ljubljana Slowenien Operations Innovative Medicines Technical Operations Okt 07, 2024
Associate Director, Talent Acquisition, Operations Hyderabad (Office) Indien People & Organization CTS Humanressourcen Okt 07, 2024
Associate Director, Talent Acquisition, R&D Hyderabad (Office) Indien People & Organization CTS Humanressourcen Okt 07, 2024
Lead Developer, Generative AI Navigator (GAIN) Platform Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 07, 2024
Sr. Prompt Engineering Specialist Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 07, 2024
Rheumatology Territory Account Specialist – Denver Metro Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 07, 2024
SCM specialist INSURGENTES Mexiko Operations Innovative Medicines Technical Operations Okt 07, 2024
Specialist Sales Consultant Field Sales (Canada) Kanada International Innovative Medicines Der Umsatz Okt 07, 2024
Director, Program Launch and Change Excellence East Hanover USA US Innovative Medicines Marketing Okt 07, 2024
Clinical Sciences Associate Director (Multiple Roles) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 07, 2024
Content & Education Specialist Hyderabad (Office) Indien Operations CTS Marketing Okt 07, 2024
Senior Analyst Commercial Analytics Hyderabad (Office) Indien Operations CTS Marketing Okt 07, 2024
Digital Quality Control specialist INSURGENTES Mexiko Operations Innovative Medicines Quality Okt 07, 2024
Tehnik vzdrževanja (m/ž/d) Mengeš Slowenien Operations Innovative Medicines Technical Operations Okt 07, 2024
FC&C Head - HUB/ECI Hyderabad (Office) Indien Finance CTS Audit und Finanzen Okt 07, 2024
Production Technician Murcia Spanien Operations Innovative Medicines Technical Operations Okt 07, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 07, 2024
Quality Operations Specialist - Batch Release INSURGENTES Mexiko Operations Innovative Medicines Quality Okt 07, 2024
Consultor Técnico Especialidades Master Santo Amaro Brasilien International Innovative Medicines Der Umsatz Okt 07, 2024
Study Start-up Team Lead Santo Amaro Brasilien Development Innovative Medicines Research & Development Okt 07, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 07, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 07, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Okt 07, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 07, 2024
(高级)医药代表 /(资深)产品专员 Tianshui (Gansu Province) China International Innovative Medicines Der Umsatz Okt 07, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Der Umsatz Okt 07, 2024
Tax Manager (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Finance Corporate Audit und Finanzen Okt 06, 2024
Regulatory Affairs Manager New South Wales (NSW) Australien Development Innovative Medicines Research & Development Okt 06, 2024
Manager Economic Modelling Hyderabad (Office) Indien Operations CTS Market Access Okt 06, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Okt 06, 2024
Associate Director, Clinical Manufacturing Operations (f/m/d) / Vodja operacij klinične proizvodnje (ž/m/d) Ljubljana Slowenien Development Innovative Medicines Research & Development Okt 04, 2024
Data Scientist/Computational Chemist (80-100%*) Basel (City) Schweiz Biomedical Research Pharma Research Data and Digital Okt 04, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.